MRD Response-adapted Allo-HSCT for Adverse-risk AML

Clinical trial NCT06301425 · RECRUITING

Trial details

NCT number: NCT06301425
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-05-24
Primary completion: 2027-05-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.